Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 1351 AL 1365

Population pharmacokinetics and standard uptake value ratio of aducanumab, an amyloid plaque-removing agent, in patients with Alzheimer's disease

Kandadi Muralidharan K, Tong X, Kowalski KG, Rajagovindan R, Lin L, Budd Haberlain S, Nestorov I.

CPT Pharmacometrics Syst Pharmacol. 2022 Jan;11(1):7-19. doi: 10.1002/psp4.12728. Epub 2021 Oct 26.

Implications of Phosphoinositide 3-Kinase-Akt (PI3K-Akt) Pathway in the Pathogenesis of Alzheimer's Disease

Kumar M, Bansal N.

Mol Neurobiol. 2022 Jan;59(1):354-385. doi: 10.1007/s12035-021-02611-7. Epub 2021 Oct 26.

The Swedish dilemma - the almost exclusive use of APPswe-based mouse models impedes adequate evaluation of alternative β-secretases

Armbrust F, Bickenbach K, Marengo L, Pietrzik C, Becker-Pauly C.

Biochim Biophys Acta Mol Cell Res. 2022 Mar;1869(3):119164. doi: 10.1016/j.bbamcr.2021.119164. Epub 2021 Oct 23.

Identification of altered exosomal microRNAs and mRNAs in Alzheimer's disease

Su L, Li R, Zhang Z, Liu J, Du J, Wei H.

Ageing Res Rev. 2022 Jan;73:101497. doi: 10.1016/j.arr.2021.101497. Epub 2021 Oct 26.

Disclosing tau tangles using PET imaging: a pharmacological review of the radiotracers available in 2021

Van Wambeke É, Gérard T, Lhommel R, Hanseeuw B.

Acta Neurol Belg. 2022 Apr;122(2):263-272. doi: 10.1007/s13760-021-01797-w. Epub 2021 Oct 28.

Oxidative stress-A direct bridge to central nervous system homeostatic dysfunction and Alzheimer's disease

Anwar MM.

Cell Biochem Funct. 2022 Jan;40(1):17-27. doi: 10.1002/cbf.3673. Epub 2021 Oct 30.

Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer's Disease

Dhapola R, Sarma P, Medhi B, Prakash A, Reddy DH.

Mol Neurobiol. 2022 Jan;59(1):535-555. doi: 10.1007/s12035-021-02612-6. Epub 2021 Nov 2.

Neuropathology of Alzheimer's Disease

Trejo-Lopez JA, Yachnis AT, Prokop S.

Neurotherapeutics. 2022 Jan;19(1):173-185. doi: 10.1007/s13311-021-01146-y. Epub 2021 Nov 2.

Chinese Herbal Medicine Adjusting Brain Microenvironment via Mediating Central Nervous System Lymphatic Drainage in Alzheimer's Disease

Zhou XB, Zhang YX, Zhou CX, Ma JJ.

Chin J Integr Med. 2022 Feb;28(2):176-184. doi: 10.1007/s11655-021-3342-5. Epub 2021 Nov 3.

Multiple roles of short-chain fatty acids in Alzheimer disease

Chen H, Meng L, Shen L.

Nutrition. 2022 Jan;93:111499. doi: 10.1016/j.nut.2021.111499. Epub 2021 Sep 23.

Therapeutic potential of quinazoline derivatives for Alzheimer's disease: A comprehensive review

Haghighijoo Z, Zamani L, Moosavi F, Emami S.

Eur J Med Chem. 2022 Jan 5;227:113949. doi: 10.1016/j.ejmech.2021.113949. Epub 2021 Oct 27.

Dissecting the complexities of Alzheimer disease with in vitro models of the human brain

Blanchard JW, Victor MB, Tsai LH.

Nat Rev Neurol. 2022 Jan;18(1):25-39. doi: 10.1038/s41582-021-00578-6. Epub 2021 Nov 8.

Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside

Walia V, Kaushik D, Mittal V, Kumar K, Verma R, Parashar J, Akter R, Rahman MH, Bhatia S, Al-Harrasi A, Karthika C, Bhattacharya T, Chopra H, Ashraf GM.

Mol Neurobiol. 2022 Jan;59(1):657-680. doi: 10.1007/s12035-021-02617-1. Epub 2021 Nov 9.

Accelerated intermittent theta-burst stimulation broadly ameliorates symptoms and cognition in Alzheimer's disease: A randomized controlled trial

Wu X, Ji GJ, Geng Z, Wang L, Yan Y, Wu Y, Xiao G, Gao L, Wei Q, Zhou S, Wei L, Tian Y, Wang K.

Brain Stimul. 2022 Jan-Feb;15(1):35-45. doi: 10.1016/j.brs.2021.11.007. Epub 2021 Nov 6.

Genetic mutations of APOEε4 carriers in cardiovascular patients lead to the development of insulin resistance and risk of Alzheimer's disease

Jabeen K, Rehman K, Akash MSH.

J Biochem Mol Toxicol. 2022 Feb;36(2):e22953. doi: 10.1002/jbt.22953. Epub 2021 Nov 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias